Role of thermodynamic, kinetic and structural factors in the recrystallization behavior of amorphous erythromycin salts

Thermochimica Acta

Volumn 582, Issue , 2014, Pages 77-85

  Nanakwani, Kapil ^a   Modi, Sameer R ^a   Kumar, Lokesh ^a   Bansal, Arvind K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Amorphous salts; Crystallization kinetics; Erythromycin; Fragility; Molecular mobility; Thermodynamic factors

Indexed keywords

ANTIBIOTICS; CRYSTALLIZATION KINETICS; DRUG DELIVERY; KINETICS; SALTS;

DRUG DELIVERY STRATEGIES; ERYTHROMYCIN; FRAGILITY; KINETICS OF CRYSTALLIZATION; MOLECULAR MOBILITY; POORLY WATER-SOLUBLE DRUGS; THERMODYNAMIC DRIVING FORCES; THERMODYNAMIC FACTORS;

THERMODYNAMICS;

EID: 84896986943     PISSN: 00406031     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tca.2014.03.001     Document Type: Article

References (41)

1. M. Rabinowitz, and N. Shankley The impact of combinatorial chemistry on drug discovery O.D.J.C.G. Smith, The Process of New Drug Discovery and Development 2006 Informa Healthcare New York 56 77
2. S.M. Berge, L.D. Bighley, and D.C. Monkhouse Pharmaceutical salts J. Pharm. Sci. 66 1977 1 19
3. A.T.M. Serajuddin Salt formation to improve drug solubility Adv. Drug Deliv. Rev. 59 2007 603 616 (Pubitemid 47285406)
4. B.C. Hancock, and G. Zografi Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1997 1 12
5. A.M. Kaushal, P. Gupta, and A.K. Bansal Amorphous drug delivery systems: molecular aspects, design, and performance Crit. Rev. Ther. Drug Carrier Syst. 21 2004 133
6. L. Yu Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Deliv. Rev. 48 2001 27 42 (Pubitemid 32454482)
7. Y. Kumar, T.K. Sharma, P. Bose, Amorphous form of losartan potassium, US20060241305 A1, 2003, pp. 1-3.
8. B. Vijayaraghavan, T. Sharma, N. Kumar, Novel amorphous form of omeprazole salts, US 20030212274 A1, 2003, pp. 1-3.
9. P. Guerrieri, A.C. Rumondor, T. Li, and L.S. Taylor Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts AAPS PharmSciTech 11 2010 1212 1222
10. V.M. Sonje, L. Kumar, V. Puri, G. Kohli, A.M. Kaushal, and A.K. Bansal Effect of counterions on the properties of amorphous atorvastatin salts Eur. J. Pharm. Sci. 44 2011 462 470
11. P. Tong, L.S. Taylor, and G. Zografi Influence of alkali metal counterions on the glass transition temperature of amorphous indomethacin salts Pharm. Res. 19 2002 649 654 (Pubitemid 34553673)
12. C.S. Towler, T. Li, H. Wikström, D.M. Remick, M.V. Sanchez-Felix, and L.S. Taylor An investigation into the influence of counterion on the properties of some amorphous organic salts Mol. Pharm. 5 2008 946 955
13. L.H. Nielsen, S. Gordon, R. Holm, A. Selen, T. Rades, and A. Müllertz Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats Eur. J. Pharm. Biopharm. 85 2013 942 951
14. L. Kumar, D. Popat, and A.K. Bansal Investigation of the atypical glass transition and recrystallization behavior of amorphous prazosin salts Pharmaceutics 3 2011 525 537
15. P. Tong, and G. Zografi Solid-state characteristics of amorphous sodium indomethacin relative to its free acid Pharm. Res. 16 1999 1186 1192 (Pubitemid 29393605)
16. P.H. Jones, E.K. Rowley, A.L. Weiss, D.L. Bishop, and A.H.C. Chun Insoluble erythromycin salts J. Pharm. Sci. 58 1969 337 339
17. K. Gupta, D. Roy, V. Subramanian, and P. Chattaraj Are strong Brønsted acids necessarily strong Lewis acids? J. Mol. Struct. Theochem. 812 2007 13 24
18. P. Allen, P. Rahn, A. Sarapu, and A. Vanderwielen Physical characterization of erythromycin: anhydrate, monohydrate, and dihydrate crystalline solids J. Pharm. Sci. 67 1978 1087 1093 (Pubitemid 8399493)
19. E. Laine, P. Kahela, R. Rajala, T. Heikkilä, K. Saarnivaara, and I. Piippo Crystal forms and bioavailability of erythromycin Int. J. Pharm. 38 1987 33 38 (Pubitemid 17148751)
20. I. Miroshnyk, L. Khriachtchev, S. Mirza, J. Rantanen, J. Heinämäki, and J. Yliruusi Insight into thermally induced phase transformations of erythromycin A dihydrate Cryst. Growth Des. 6 2006 369 374 (Pubitemid 43242095)
21. D.Q.M. Craig, P.G. Royall, V.L. Kett, and M.L. Hopton The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems Int. J. Pharm. 179 1999 179 207 (Pubitemid 29131430)
22. M.E. Matteucci, M.A. Miller, R.O. Williams III, and K.P. Johnston Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties J. Phys. Chem. B 112 2008 16675 16681
23. C.A. Angell Relaxation in liquids, polymers and plastic crystals - strong/fragile patterns and problems J. Non-Cryst. Solids 131 1991 13 31 (Pubitemid 21677972)
24. g and the fragility index of indomethacin, predicted from the influence of the heating rate on the temperature position and on the intensity of thermally stimulated depolarization current peak Pharm. Res. 19 2002 1879 1884 (Pubitemid 36016037)
25. A.M. Kaushal, P. Gupta, and B. AK Amorphous drug delivery systems: molecular aspects, design, and performance Crit. Rev. Ther. Drug Carrier Sys. 21 2004 133
26. Y. Aso, S. Yoshioka, and S. Kojima Relationship between water mobility, measured as nuclear magnetic relaxation time, and the crystallization rate of amorphous nifedipine in the presence of some pharmaceutical excipients Chem. Pharm. Bull. 44 1996 1065 1067 (Pubitemid 26193458)
27. Y. Aso, S. Yoshioka, and S. Kojima Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times J. Pharm. Sci. 89 2000 408 416 (Pubitemid 30152440)
28. P. Gupta, G. Chawla, and A.K. Bansal Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility Mol. Pharm. 1 2004 406 413
29. D. Zhou, G.G.Z. Zhang, D. Law, D.J.W. Grant, and E.A. Schmitt Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility J. Pharm. Sci. 91 2002 1863 1872 (Pubitemid 34810531)
30. P. Gupta, and A.K. Bansal Molecular interactions in celecoxib-PVP- meglumine amorphous system J. Pharm. Pharmcol. 57 2005 303 310 (Pubitemid 40314428)
31. S.L. Shamblin, and G. Zografi The effects of absorbed water on the properties of amorphous mixtures containing sucrose Pharm. Res. 16 1999 1119 1124 (Pubitemid 29368163)
32. R. Surana, A. Pyne, and R. Suryanarayanan Effect of preparation method on physical properties of amorphous trehalose Pharm. Res. 21 2004 1167 1176 (Pubitemid 38960768)
33. C. Bhugra, and M.J. Pikal Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state J. Pharm. Sci. 97 2008 1329 1349
34. M. Siniti, J. Carre, J. Letoffe, J. Bastide, and P. Claudy The thermal behavior of hexitols. Part 1. Vitrification and crystallization of iditol, mannitol, sorbitol, and dulcitol Thermochim. Acta 224 1993 97 104
35. K.A. Graeser, J.E. Patterson, and T. Rades Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin Curr. Drug Deliv. 6 2009 374 382
36. K.A. Graeser, J.E. Patterson, J.A. Zeitler, K.C. Gordon, and T. Rades Correlating thermodynamic and kinetic parameters with amorphous stability Eur. J. Pharm. Sci. 37 2009 492 498
37. R.G. Parr, and W. Yang Density-functional theory of the electronic structure of molecules Annu. Rev. Phys. Chem. 46 1995 701 728
38. R.H. Hatley Glass fragility and the stability of pharmaceutical preparations-excipient selection Pharm. Dev. Technol. 2 1997 257 264 (Pubitemid 28252521)
39. S.P. Bhardwaj, K.K. Arora, E. Kwong, A. Templeton, S.-D. Clas, and R. Suryanarayanan Correlation between molecular mobility and physical stability of amorphous itraconazole Mol. Pharm. 10 2013 694 700
40. D. Zhou, G.G.Z. Zhang, D. Law, D.J.W. Grant, and E.A. Schmitt Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin Mol. Pharm. 5 2008 927 936
41. A.M. Kaushal, and A.K. Bansal Thermodynamic behavior of glassy state of structurally related compounds Eur. J. Pharm. Biopharm. 69 2008 1067 1076